Skip to search.
 FTSE 100 Up 0.04%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
7.03 Down 0.07(0.99%) 26 May 21:00
|After Hours: : 7.09 Up 0.06 (0.87%) 21:39
Prev Close:7.10
Open:7.12
Bid:6.50 x 1000
Ask:7.10 x 1000
1y Target Est:12.63
Beta:1.38756
Earnings Date:3 Aug - 8 Aug (Est.)
Day's Range:7.00 - 7.20
52wk Range:4.99 - 18.83
Volume:1,763,190
Avg Vol (3m):2,526,070
Market Cap:893.16m
P/E (ttm):N/A
EPS (ttm):-1.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for FOLD at this time.

Comparison

Symbol% ChgMkt Cap
FOLDDown 0.99%893.16m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.37
Quarterly EPS Est (Jun-16) :-0.33
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback